骨质疏松机会性筛查的临床实施框架
本文围绕放射科、IT与运营团队、临床医护团队三类利益相关方,提出机会性筛查从算法验证走向临床落地的实施框架。以大型学术医学中心开展的CT骨质疏松机会性筛查为例,说明各团队面临的关键决策。框架旨在广泛适用于各类机会性筛查应用。
要点
- 机会性筛查依托既有的、因无关常规临床指征完成的影像检查来提取定量生物标志物。
- 实施需放射科、IT与运营、临床团队三方协同,任一环节缺失都会影响项目可靠性。
- 以CT骨质疏松机会性筛查为范例,这一框架可用于其他机会性筛查向临床转化。
核心结论
- 成功部署机会性筛查需要放射科、IT与运营团队、临床医护团队协调参与,各自的关键决策共同决定项目能否可靠运行并为患者带来获益。
- 本文提出的实施框架以三类利益相关方为组织核心,在大型学术医学中心的CT骨质疏松筛查项目中得到应用。
研究设计与样本
- 本文为实践框架类文章,围绕三类利益相关方的决策路径展开论述。
- 结合一所大型学术医学中心开发CT骨质疏松机会性筛查项目的经验进行说明。
临床应用与阅片要点
- 机会性筛查不增加额外扫描,利用已完成的无关联常规影像检查即可提取定量生物标志物。
- 人工智能工具使机会性筛查的大规模部署在技术上日益可行,但从验证算法到运行中的临床项目路径仍不明确。
- 阅片与报告流程应纳入与IT系统对接的自动化结果输出,并明确后续临床处理路径。
局限性
- 从经过验证的算法到正常运行的临床项目之间的路径仍缺乏清晰界定,前瞻性大规模实施尚不多见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Opportunistic screening leverages existing imaging examinations performed for unrelated routine clinical indications to systematically extract quantitative biomarkers. Artificial intelligence tools have made deployment at scale increasingly feasible. However, the pathway from a validated algorithm to a functioning clinical program remains poorly defined, and prospective implementation at scale is uncommon. Successful deployment requires coordinated engagement from radiologists, IT and operational teams, and clinical care teams, each facing distinct decisions that determine whether a program functions reliably and delivers patient benefit. This article presents a practical framework for opportunistic screening implementation organized around these three stakeholder groups. We apply this framework to opportunistic CT osteoporosis screening, drawing on our experience developing such a program at a large academic medical center. The framework presented is intended to be broadly applicable across opportunistic screening applications as the field moves from algorithmic validation toward clinical translation.
引用
- Dogra, Bussey, Dane, et al. Clinical Implementation of Opportunistic Screening for Osteoporosis. AJR Am J Roentgenol. 2026. PMID: 42308093. doi:10.2214/AJR.26.34956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。